Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Active not recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Sedentary Behavior 1Neoplasm Metastasis 1Motor Activity 1Chronic Disease 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Fitness Trackers × Clear all
NCT06840028 2026-05-01

Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors

The University of Tennessee, Knoxville

Phase NA Active not recruiting
160 enrolled

Chronic Disease, Motor Activity, Neoplasms, Sedentary Behavior

NCT03757182 2024-08-27

DigiSTEPS

Cedars-Sinai Medical Center

Active not recruiting
80 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡